Condition: NEUROBLASTOMA, SUSCEPTIBILITY TO, 3
rs1057520019
in
ALK
gene and
NEUROBLASTOMA, SUSCEPTIBILITY TO, 3
PMID 18923525
2008 Activating mutations in ALK provide a therapeutic target in neuroblastoma.
PMID 18724359
2008 Identification of ALK as a major familial neuroblastoma predisposition gene.
PMID 18923523
2008 Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
PMID 21242967
2011 The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.